PostEra
ActiveAI-nativeMedicinal Chemistry powered by Machine Learning
What it does
PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.
Its site says now · captured 2026-08-23
PostEra is building an AI-first biotech. We use Proton, our AI platform for medicinal chemistry, to discover and develop new medicines for patients.
Next to it in Healthcare and bio · AI-powered medicinal chemistry for drug discovery
- Abalone BioY Combinator W20
We create activating antibodies to treat diseases others can’t.
- Known MedicineY Combinator S20
Combining 3D cell culture & AI to translate drugs to clinical success
- CellChorusY Combinator S21
The dynamic single-cell analysis company
- Harmonic DiscoveryY Combinator S21
Multi-targeted therapeutics to treat complex diseases
- Output BiosciencesY Combinator S21
The foundation for the next era of biology
- Parallel BioY Combinator S21
Using the immune system to cure disease
- Synkrino BiotherapeuticsY Combinator S18
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
- VemiCo LtdSOSV SOSV IndieBio RebelBio 08
From gut microbiota to therapeutics via AI and synthetic biology